| SC 13D/A | 2022-07-12 | 3D Investment Partners Pte. Ltd. | MEDICINOVA INC | 5,502,047 | 11.2% | EDGAR |
| SC 13G/A | 2021-07-12 | BlackRock Inc. | MEDICINOVA INC | 1,127,922 | 2.3% | EDGAR |
| SC 13G/A | 2021-01-29 | BlackRock Inc. | MEDICINOVA INC | 3,313,971 | 7.4% | EDGAR |
| SC 13D | 2021-01-21 | 3D Investment Partners Pte. Ltd. | MEDICINOVA INC | 5,502,047 | 11.3% | EDGAR |
| SC 13G/A | 2020-02-05 | BlackRock Inc. | MEDICINOVA INC | 2,835,590 | 6.5% | EDGAR |
| SC 13G | 2019-02-08 | BlackRock Inc. | MEDICINOVA INC | 2,913,245 | 7.0% | EDGAR |
| SC 13G/A | 2018-05-17 | Satomi Hajime | MEDICINOVA INC | 2,217,000 | 5.3% | EDGAR |
| SC 13G/A | 2018-01-09 | BlackRock Inc. | MEDICINOVA INC | 1,711,194 | 4.7% | EDGAR |
| SC 13D/A | 2017-06-14 | Kissei Pharmaceutical Co., Ltd. | MEDICINOVA INC | 1,400,000 | 4.1% | EDGAR |
| SC 13G/A | 2017-02-14 | FMR LLC | MEDICINOVA INC | 1,470,799 | 4.3% | EDGAR |
| SC 13G | 2017-01-30 | BlackRock Inc. | MEDICINOVA INC | 1,974,411 | 5.7% | EDGAR |
| SC 13G/A | 2016-07-11 | FMR LLC | MEDICINOVA INC | 1,827,500 | 5.7% | EDGAR |
| SC 13D/A | 2016-05-17 | Kissei Pharmaceutical Co., Ltd. | MEDICINOVA INC | 2,200,000 | 6.4% | EDGAR |
| SC 13D/A | 2016-02-12 | ESSEX WOODLANDS HEALTH VENTURES FUND VI L P | MEDICINOVA INC | 1,210,370 | 4.0% | EDGAR |
| SC 13G | 2015-09-10 | FMR LLC | MEDICINOVA INC | 3,507,800 | 11.7% | EDGAR |
| SC 13G | 2013-05-20 | Satomi Hajime | MEDICINOVA INC | 2,217,000 | 10.0% | EDGAR |
| SC 13G/A | 2013-02-14 | Pyxis Capital, L.P. /DE | MEDICINOVA INC | 121,816 | 0.7% | EDGAR |
| SC 13G/A | 2012-02-14 | BURLINGAME ASSET MANAGEMENT, LLC | MEDICINOVA INC | 0 | 0.0% | EDGAR |
| SC 13G | 2012-02-09 | Pyxis Capital, L.P. | MEDICINOVA INC | 843,369 | 5.2% | EDGAR |
| SC 13G/A | 2012-01-23 | Southpaw Credit Opportunity Master Fund, L.P. | MEDICINOVA INC | 0 | 0.0% | EDGAR |